Jim Simons's position in Biogen is currently worth $145 Million. That's 0.22% of their equity portfolio (92nd largest holding). The first Biogen trade was made in Q2 2013. Since then Jim Simons bought shares sixteen more times and sold shares on 26 occasions. The investor's estimated purchase price is $201 Million, resulting in a loss of 28%.